These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20734458)

  • 1. Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma.
    Kim HN; Yu L; Kim NY; Lee IK; Kim YK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
    Am J Hematol; 2010 Oct; 85(10):822-4. PubMed ID: 20734458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphoma.
    Havranek O; Spacek M; Hubacek P; Mocikova H; Benesova K; Soucek P; Trneny M; Kleibl Z
    Leuk Res; 2011 Aug; 35(8):1117-9. PubMed ID: 21546086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
    Kim HN; Lee IK; Kim YK; Tran HT; Yang DH; Lee JJ; Shin MH; Park KS; Shin MG; Choi JS; Kim HJ
    Br J Haematol; 2008 Feb; 140(3):287-94. PubMed ID: 18042267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.
    Kim HN; Kim NY; Yu L; Kim YK; Lee IK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
    Am J Hematol; 2009 Dec; 84(12):821-5. PubMed ID: 19899130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
    Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
    Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.
    Sameer AS; Shah ZA; Syeed N; Banday MZ; Bashir SM; Bhat BA; Siddiqi MA
    Genet Mol Res; 2010 Apr; 9(2):651-60. PubMed ID: 20449797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
    Hosny G; Farahat N; Hainaut P
    Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
    Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
    Pandith AA; Shah ZA; Khan NP; Rasool R; Afroze D; Yousuf A; Wani S; Siddiqi M
    Cancer Genet Cytogenet; 2010 Dec; 203(2):263-8. PubMed ID: 21156242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
    Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
    Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
    Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
    Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
    Wang SS; Cerhan JR; Hartge P; Davis S; Cozen W; Severson RK; Chatterjee N; Yeager M; Chanock SJ; Rothman N
    Cancer Res; 2006 Oct; 66(19):9771-80. PubMed ID: 17018637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
    Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma.
    El Hallani S; Ducray F; Idbaih A; Marie Y; Boisselier B; Colin C; Laigle-Donadey F; Rodéro M; Chinot O; Thillet J; Hoang-Xuan K; Delattre JY; Sanson M
    Neurology; 2009 Jan; 72(4):332-6. PubMed ID: 19171829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
    Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis between the Cdc6 G1321A polymorphism and the risk for non-Hodgkin lymphoma and hepatocellular carcinoma.
    Xiong XD; Qiu FE; Fang JH; Shen Y; Liang C; Jiang W; Zhuang SM
    Mutat Res; 2009 Mar; 662(1-2):10-5. PubMed ID: 19101572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
    Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.